GLP-1 and weight loss: the scale is not the whole story

Treatments in the GLP-1 receptor agonist family have become central to the weight-loss conversation. Their effectiveness is often reduced to an impressive number on the scale. Yet two people can lose the same amount of weight with very different changes in body composition.

Some of the weight lost can be fat mass, but some can also be lean mass. Lean mass includes muscle, but also water, organs and other tissues. The goal is not to treat every change in lean mass as alarming, but to understand what studies actually measure and why strength matters alongside weight.

In this article, GLP-1 refers to a family of treatments prescribed in specific medical situations. It does not recommend a medication or offer a personalised plan. It provides context for reading the information circulating around this topic.

GLP-1 receptor agonists and treatments that also act on GIP change several signals involved in appetite and blood-glucose regulation. Many people eat less, sometimes with a reduced sense of hunger or less persistent food noise. Lower energy intake can lead to substantial weight loss.

But the medication does not decide on its own where every lost kilo comes from. Meal composition, activity, rate of weight loss, age, health status and starting point all influence the response. Weight loss can also change nutritional needs and make it harder to eat enough when appetite drops sharply.

This is why results should not be judged by weight alone. Body composition and the ability to maintain everyday activities provide a fuller picture of progress.

The term “lean mass” is often used as a synonym for muscle, but that is not accurate. Bioimpedance scales and scans estimate different body compartments, each with a margin of error. A drop in lean mass can reflect a change in water or glycogen, not only a loss of muscle fibres.

That distinction does not make the issue unimportant. Skeletal muscle contributes to strength, balance, movement and the ability to remain independent. A reduction in weight accompanied by lower strength or performance therefore deserves attention, even if the number on the scale keeps falling.

Researchers consequently recommend talking about preserving lean mass and muscle function, rather than claiming that every part of weight lost beyond fat is muscle. This distinction avoids two opposite mistakes: dismissing a real functional problem or creating unnecessary alarm from an imperfect measurement.

The available results do not provide one percentage that applies to everyone. An analysis published in the Journal of the American College of Cardiology in 2026 reported that the lean-mass share of weight lost ranged from 5.7% to 38.9% across the studies reviewed. Methods and populations differed, and most studies did not properly assess strength or performance.

A review in the Annals of Internal Medicine estimated that around 28.3% of median weight loss in incretin studies corresponded to muscle-based indices. This must not be read as proof that 28.3% of muscle is systematically destroyed: the indices, devices and thresholds used are not the same from one study to another.

A recent review on musculoskeletal preservation makes an important point: any substantial weight loss can reduce lean mass, whatever method is used. The real question is therefore the overall quality of weight loss, including strength, mobility, bone health and adequate nutrition, not only how quickly the kilos disappear.

Research and supportive-care recommendations point towards a simple approach: avoid letting reduced appetite lead to an inadequate diet, and keep a regular muscle stimulus. Protein needs are not identical for everyone. They depend on age, body size, activity, total intake and medical circumstances. A healthcare professional can help set an appropriate target, especially when appetite is very low.

Strength training is the other central lever. It does not need to be an extreme programme: bodyweight exercises, light loads or machines can provide a useful stimulus when adapted to a person’s abilities and any contraindications. Our guide to strength training versus cardio explains why the two do not serve exactly the same goals.

Adequate food, reasonable progression and proper muscle recovery matter more than a miracle food or one universal protein target. If nausea, vomiting, diarrhoea or loss of appetite makes it difficult to eat or drink properly, speak promptly with the team managing the treatment.

Weight is still useful, but it should be placed in a broader picture. Changes in waist circumference, strength in familiar movements, endurance, day-to-day energy and the ability to perform normal activities provide additional information. A body-composition assessment may sometimes help, but it should be interpreted in light of the method used and the clinical context.

Smartwatches, connected scales and before-and-after photos can help observe a trend, not make a diagnosis. Hydration, measurement time and the device used can all change the result substantially. Comparing measurements taken under similar conditions is more useful than reacting to a single number.

If strength drops noticeably, fatigue persists, eating becomes difficult or weight loss is very rapid, contact the doctor or dietitian supporting the process. Ember can help you observe habits, but it does not replace clinical follow-up.